Join Emerging Researchers Kristin Dahl, University of Colorado Anschutz Medical Campus, and Juliet Girard, University of California Los Angeles, for their talks in the Specialized Cell and Evolution track. Speakers submitted top-scoring abstracts to the Cell Bio 2021 meeting that were not selected for talks.
University of Colorado Anschutz Medical Campus
Kristin received her undergraduate degree from the Ohio State University. After graduating, she worked with Dr. Atom Sarkar; and used atomic force microscopy to study the biophysical properties of proteins associated with brain pathology. She then moved to Colorado to work with Dr. Chad Pearson to study centriole biogenesis. She started graduate school in 2016 at the University of Colorado Anschutz Medical Campus in the Molecular Biology program. She is currently working with Dr. Wendy Macklin to understand how the myelin-producing glial cell, oligodendrocyte, regulates changes in the actin cytoskeleton network during differentiation to generate myelin. Her broader interest is in studying how the extracellular environment interacts with intracellular signaling pathways that result in different cellular outcomes.
University of California Los Angeles, Department of Molecular, Cell, and Developmental Biology
Juliet Girard received her bachelor’s degree in Biochemical Sciences, cum laude from Harvard University in 2007 and her Ph.D. in Biochemistry and Molecular Biology from the University of California San Francisco in 2015. She is currently a postdoc in the Banerjee lab at the University of California Los Angeles and will soon be starting her own lab as an Assistant Professor at the University of Massachusetts Boston. Her research addresses how intercellular signaling and the gene expression it triggers affect the development of blood cells (hematopoiesis). In particular, she investigates how undifferentiated progenitor cells differentiate into a variety of specialized blood cell types. Insights into the molecular mechanisms that underlie blood formation are necessary to understand the causes of blood diseases such as leukemia and may aid in the development of new therapies.